SIFI > International Markets
International Markets
In the last years SIFI has undergone a virtuous growth of its business, evolving into an industrial group of companies, consolidating domestic leadership and expanding into international markets.

Internationalization for SIFI Group means exporting a brand that is synonymous with specialization and tradition in ophthalmology, quality and innovation, ethics and professionalism, scientific education and proximity to physicians and patients, high medical and technological contents and commitment to social responsibility.

SIFI group has acquired a strong presence in the Americas and in European countries, either through its own subsidiaries or through partnering commercial distributors.

Currently the global key markets include Mexico, Romania, Spain, UK, Russia and Turkey where SIFI already has a significant presence through exclusive distributors.

Direct subsidiaries are present in Mexico (Laboratorios SIFI de México S.A. de C.V.) and Romania (Oftafarma srl).

share & tag us with
#EyeCare #eyeinfo #health #innovation #business #eye #vision #leadership #pharma
#Development
“Vision is the art of seeing what is invisible to others.”
Jonathan Swift

 
 
International Markets In the last years SIFI has undergone a virtuous growth of its business, evolving into an industrial group of companies, consolidating domestic leadership and expanding...
 
Disclosure of Transfers of value    SIFI is a pharmaceutical company committed to fulfilling the needs of its customers, both patients and ophthalmologists.   SIFI strongly...
 
Quality We CARE for patients; all patients, even those frequently left behind by the industry, such as individuals afflicted by rare diseases.   SIFI’s 80-year long history is distinguished...

On our Social Channels

From our News Center

SIFI to strengthen R&D Pipeline with Pro-Ocular™ containing a neurosteroid with novel dosage delivery system that activates neural signaling to produce endogenous tear film without...
 

 

08 June

Don't miss the SIFI Symposium at the XIX G.I.Vre Italian Group of Vitreoretinal Surgery on treatment of diabetic macular edema presenting three-year data of the "real...
Follow Us!